TRACON Pharmaceuticals Ownership
| TCONDelisted Stock | USD 1.60 0.55 52.38% |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
TRACON |
TRACON Stock Ownership Analysis
The company recorded earning per share (EPS) of 106.4. TRACON Pharmaceuticals last dividend was issued on the 8th of November 2019. The entity had 1:20 split on the 10th of April 2024. TRACON Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for cancer in the United States. TRACON Pharmaceuticals, Inc. was incorporated in 2004 and is headquartered in San Diego, California. Tracon Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 19 people. To find out more about TRACON Pharmaceuticals contact the company at 858 550 0780 or learn more at https://www.traconpharma.com.TRACON Pharmaceuticals Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific TRACON Pharmaceuticals insiders, such as employees or executives, is commonly permitted as long as it does not rely on TRACON Pharmaceuticals' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases TRACON Pharmaceuticals insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Charles Theuer over six months ago Acquisition by Charles Theuer of 3500 shares of TRACON Pharmaceuticals at 0.1333 subject to Rule 16b-3 | ||
Charles Theuer over six months ago Acquisition by Charles Theuer of 518300 shares of TRACON Pharmaceuticals at 0. subject to Rule 16b-3 | ||
Charles Theuer over six months ago Acquisition by Charles Theuer of 4500 shares of TRACON Pharmaceuticals at 1.85 subject to Rule 16b-3 | ||
Charles Theuer over a year ago Purchase by Charles Theuer of 99 shares of TRACON Pharmaceuticals | ||
Twiford J Rainer over a year ago Acquisition by Twiford J Rainer of 18000 shares of TRACON Pharmaceuticals subject to Rule 16b-3 | ||
Charles Theuer over a year ago Purchase by Charles Theuer of 200 shares of TRACON Pharmaceuticals | ||
Charles Theuer over a year ago Acquisition by Charles Theuer of 332000 shares of TRACON Pharmaceuticals subject to Rule 16b-3 |
TRACON Pharmaceuticals Outstanding Bonds
TRACON Pharmaceuticals issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. TRACON Pharmaceuticals uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most TRACON bonds can be classified according to their maturity, which is the date when TRACON Pharmaceuticals has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| TOYOTA 365 18 AUG 25 Corp BondUS89236TKF11 | View | |
| TOYOTA 445 29 JUN 29 Corp BondUS89236TKD62 | View | |
| TOYOTA 395 30 JUN 25 Corp BondUS89236TKC89 | View | |
| TOYOTA 2362 25 MAR 31 Corp BondUS892331AN94 | View | |
| TOYOTA 305 22 MAR 27 Corp BondUS89236TJZ93 | View | |
| TOYOTA 24 13 JAN 32 Corp BondUS89236TJW62 | View | |
| US892356AA40 Corp BondUS892356AA40 | View | |
| TOYOTA 19 13 JAN 27 Corp BondUS89236TJV89 | View |
Pair Trading with TRACON Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if TRACON Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TRACON Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving together with TRACON Stock
Moving against TRACON Stock
| 0.56 | VERA | Vera Therapeutics | PairCorr |
| 0.51 | DMAC | DiaMedica Therapeutics Upward Rally | PairCorr |
| 0.49 | VCYT | Veracyte Buyout Trend | PairCorr |
| 0.48 | DRUG | Bright Minds Biosciences | PairCorr |
| 0.47 | DSGN | Design Therapeutics Upward Rally | PairCorr |
The ability to find closely correlated positions to TRACON Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace TRACON Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back TRACON Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling TRACON Pharmaceuticals to buy it.
The correlation of TRACON Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as TRACON Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if TRACON Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for TRACON Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Consideration for investing in TRACON Stock
If you are still planning to invest in TRACON Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the TRACON Pharmaceuticals' history and understand the potential risks before investing.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |